Latest post

The new Perspectives Magazine 2020 is here

The new issue of Oxurion Perspectives magazine is here. Read about last year's highlights and the ambitious times ahead.

back of the eye diseases, science community,

Pravin Dugel, M.D.: “Biological signal for efficacy of THR-149”

“As an investigator of THR-149, I was encouraged to see the results from its clinical phase 1 trial", Pravin Dugel, M.D., says.